M-012 (Merganser)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameM-012 (Merganser)
Drug Alias Namehepcidin mimetic peptides (Merganser)minihepcidins (Merganser)hepcidin mimetic peptides (UCLA)M-009
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionHepcidin modulators
TargetsHepcidin
Therapy Area/IndicationsSickle Cell CrisisIron Overloadbeta-Thalassemia +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California, Los Angeles
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerganser BiotechUniversity Of California, Los Angeles
Active IndicationsN/A
Inactive IndicationsSickle Cell CrisisIron Overloadbeta-Thalassemia +[5] 

Other Information

ATC CodeN/A
Related LinksN/A